641 - 650 of 5882 Results
Title
Year
- Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function2023OPENTitle: Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic functionJournal Name: NeuronPublisher: Elsevier BVVol: 111Issue #: 24Start Page: 4006End Page: 4023.e10Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neuron.2023.11.020Best OA location URL: http://www.cell.com/article/S0896627323008942/pdfCitation Count: 51
- The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole Polinski2023OPENTitle: The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole PolinskiJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 16Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.050605Best OA location URL: https://journals.biologists.com/dmm/article-pdf/16/12/dmm050605/3311458/dmm050605.pdfCitation Count: 0
- Challenges and innovations in brain PET analysis of neurodegenerative disorders: a mini-review on partial volume effects, small brain region studies, and reference region selection2023OPENTitle: Challenges and innovations in brain PET analysis of neurodegenerative disorders: a mini-review on partial volume effects, small brain region studies, and reference region selectionJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2023.1293847Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2023.1293847/pdf?isPublishedV2=FalseCitation Count: 4
- Regulation of expression quantitative trait loci by SVA retrotransposons within the major histocompatibility complex2023OPENTitle: Regulation of expression quantitative trait loci by SVA retrotransposons within the major histocompatibility complexJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15353702231209411Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/15353702231209411Citation Count: 6
- Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanism2023OPENTitle: Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanismJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91083Best OA location URL: https://github.com/elifesciences/enhanced-preprints-data/raw/master/data/91083/v1/91083-v1.pdfCitation Count: 1
-
OPENTitle: Cell-free RNA signatures predict Alzheimer’s diseaseJournal Name: iSciencePublisher: Elsevier BVVol: 26Issue #: 12Start Page: 108534End Page: 108534Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.isci.2023.108534Best OA location URL: http://www.cell.com/article/S2589004223026111/pdfCitation Count: 4
- Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications2023OPENTitle: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91645.2Best OA location URL: https://doi.org/10.7554/elife.91645.2Citation Count: 25
- Co‐Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications2023OPENTitle: Co‐Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial ImplicationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 3Start Page: 312End Page: 314Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13890Citation Count: 1
- Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation2023OPENTitle: Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 46Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adi8716Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adi8716?download=trueCitation Count: 78
- In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy Biomarker2023OPENTitle: In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy BiomarkerJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 22Start Page: 16445End Page: 16445Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms242216445Best OA location URL: https://www.mdpi.com/1422-0067/24/22/16445/pdf?version=1700208971Citation Count: 0